Medications

Enzyme replacement therapy approved for late-onset Pompe disease

(HealthDay)—Nexviazyme (avalglucosidase alfa-ngpt) was approved for the treatment of the rare inherited disorder late-onset Pompe disease in patients 1 year of age and older, the U.S. Food and Drug Administration announced ...

Diseases, Conditions, Syndromes

Recurrent infections of salmonella can lead to colitis

An international research group, led by Jamey Marth, Ph.D., a professor at Sanford Burnham Prebys, has shown that the Neuraminidase 3 (Neu3) enzyme is responsible for the onset and progression of colitis—a chronic digestive ...

Diseases, Conditions, Syndromes

A new treatment for rare muscular disease

Rare diseases are sometimes the most difficult to treat because of a lack of research and fewer participants to study.

HIV & AIDS

Nanozymes that can block HIV reactivation

Researchers at the Indian Institute of Science (IISc) have developed artificial enzymes that can successfully block reactivation and replication of the Human Immunodeficiency Virus (HIV) in the host's immune cells.

Medical research

Researchers develop promising way to find new cancer drugs

All the cells in the human body share the same genes. But how our genes are expressed determines whether a cell becomes a brain cell or a liver cell. In addition, changes in gene expression often play a significant role in ...

Medical research

Good news for menopausal women taking hops supplements

Hop-based dietary supplements that many women use to ease the night sweats and hot flashes commonly reported during menopause aren't likely to cause drug interactions, new research from Oregon State University's Linus Pauling ...

page 2 from 9